University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Parathyroid hormone-related protein induces cell survival in human renal cell carcinoma through the PI3K Akt pathway: evidence for a critical role for integrin-linked kinase and nuclear factor kappa B.

Agouni, Abdelali, Sourbier, C, Danilin, S, Rothhut, S, Lindner, V, Jacqmin, D, Helwig, JJ, Lang, H and Massfelder, T (2007) Parathyroid hormone-related protein induces cell survival in human renal cell carcinoma through the PI3K Akt pathway: evidence for a critical role for integrin-linked kinase and nuclear factor kappa B. Carcinogenesis, 28 (9). pp. 1893-1901.

[img] Text
Parathyroid hormone-related protein induces cell survival in human renal cell carcinoma through the PI3K Akt pathway evidence for a critical role for integrin-linked kinase.pdf - Version of Record
Restricted to Repository staff only

Download (689kB)

Abstract

We have recently shown that parathyroid hormone-related protein (PTHrP), a cytokine-like polyprotein, is critical for human renal cell carcinoma (RCC) growth by inhibiting tumor cell apoptosis. Here, we have explored mechanisms by which PTHrP controls tumor cell survival. Using specific inhibitors of phosphoinositide 3-kinase (PI3K) and depletion of Akt kinase by RNA interference, we established that PTHrP is one of the main factor involved in the constitutive activation of this pathway in human RCC, independently of von Hippel-Lindau (VHL) tumor suppressor gene expression. Interestingly, PTHrP induced phosphorylation of Akt at S473 but had no influence on phosphorylation at T308. Through transfection with integrin-linked kinase (ILK) constructs and RNA interference, we provide evidence that ILK is involved in human RCC cell survival. PTHrP activates ILK which then acts as a phosphoinositide-dependent kinase (PDK)-2 or a facilitator protein to phosphorylate Akt at S473. Among other kinases tested, only ILK was shown to exert this function in RCC. Using specific inhibitors, western blot and transcription assay, we identified nuclear factor kappa B (NF-kappaB) as the downstream Akt target regulated by PTHrP. Since RCC remains refractory to current therapies, our results establish that the PI3K/ILK/Akt/NF-kappaB axis is a promising target for therapeutic intervention.

Item Type: Article
Authors :
NameEmailORCID
Agouni, Abdelalia.agouni@surrey.ac.ukUNSPECIFIED
Sourbier, CUNSPECIFIEDUNSPECIFIED
Danilin, SUNSPECIFIEDUNSPECIFIED
Rothhut, SUNSPECIFIEDUNSPECIFIED
Lindner, VUNSPECIFIEDUNSPECIFIED
Jacqmin, DUNSPECIFIEDUNSPECIFIED
Helwig, JJUNSPECIFIEDUNSPECIFIED
Lang, HUNSPECIFIEDUNSPECIFIED
Massfelder, TUNSPECIFIEDUNSPECIFIED
Date : 29 April 2007
Identification Number : 10.1093/carcin/bgm106
Copyright Disclaimer : Copyright The Author 2007. Published by Oxford University Press. All rights reserved.
Uncontrolled Keywords : Apoptosis, Carcinoma, Renal Cell, Carrier Proteins, Cell Division, Cell Line, Tumor, Cell Survival, Humans, Kidney Neoplasms, NF-kappa B, Parathyroid Hormone-Related Protein, Phosphatidylinositol 3-Kinases, Protein-Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt, RNA Interference, Transfection
Depositing User : Symplectic Elements
Date Deposited : 26 Jul 2017 17:42
Last Modified : 26 Jul 2017 17:42
URI: http://epubs.surrey.ac.uk/id/eprint/158110

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800